Aarkstore - Vasculitis - Pipeline Review, H2 2014

1
Vasculitis - Pipeline Review, H2 2014
Healthcare Market Research Report
2
Summary

• Vasculitis - Pipeline Review, H2 2014, provides
  an overview of the Vasculitiss therapeutic
  pipeline.
• This report provides comprehensive information
  on the therapeutic development for Vasculitis,
  complete with comparative analysis at various
  stages, therapeutics assessment by drug target,
  mechanism of action (MoA), route of
  administration (RoA) and molecule type, along
  with latest updates, and featured news and press
  releases. It also reviews key players involved in
  the therapeutic development for Vasculitis and
  special features on late-stage and discontinued
  projects.
• Global Markets Directs report features
  investigational drugs from across globe covering
  over 20 therapy areas and nearly 3,000
  indications. The report is built using data and
  information sourced from Global Markets Directs
  proprietary databases, Company/University
  websites, SEC filings, investor presentations and
  featured press releases from company/university
  sites and industry-specific third party sources,
  put together by Global Markets Directs team.

3
Scope

• - The report provides a snapshot of the global
  therapeutic landscape of Vasculitis- The report
  reviews key pipeline products under drug profile
  section which includes, product description, MoA
  and RD brief, licensing and collaboration
  details other developmental activities - The
  report reviews key players involved in the
  therapeutics development for Vasculitis and
  enlists all their major and minor projects- The
  report summarizes all the dormant and
  discontinued pipeline projects - A review of the
  Vasculitis products under development by
  companies and universities/research institutes
  based on information derived from company and
  industry-specific sources- Pipeline products
  coverage based on various stages of development
  ranging from pre-registration till discovery and
  undisclosed stages

• Browse full report or Sample Request _at_
• http//www.aarkstore.com/healthcare/89757/vasculit
  is-pipeline-review-h2-2014

4
Reasons to buy

• - Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies- Identify
  emerging players with potentially strong product
  portfolio and create effective counter-strategies
  to gain competitive advantage- Develop strategic
  initiatives by understanding the focus areas of
  leading companies- Identify and understand
  important and diverse types of therapeutics under
  development for Vasculitis- Plan mergers and
  acquisitions effectively by identifying key
  players of the most promising pipeline- Devise
  corrective measures for pipeline projects by
  understanding Vasculitis pipeline depth and focus
  of Indication therapeutics- Develop and design
  in-licensing and out-licensing strategies by
  identifying prospective partners with the most
  attractive projects to enhance and expand
  business potential and Scope- Modify the
  therapeutic portfolio by identifying discontinued
  projects and understanding the factors that drove
  them from pipeline

5
Table of Content

• Introduction 7Global Markets Direct Report
  Coverage 7Vasculitis Overview 8Therapeutics
  Development 9Pipeline Products for Vasculitis -
  Overview 9Pipeline Products for Vasculitis -
  Comparative Analysis 10Vasculitis - Therapeutics
  under Development by Companies 11Vasculitis -
  Pipeline Products Glance 13Late Stage Products
  13Clinical Stage Products 14Early Stage
  Products 15Vasculitis - Products under
  Development by Companies 16Vasculitis -
  Companies Involved in Therapeutics Development
  17AnGes MG, Inc. 17Anthera Pharmaceuticals Inc.
  18Aprogen, Inc. 19ChemoCentryx, Inc. 20

6
List of Tables

• Number of Products under Development for
  Vasculitis, H2 2014 9Number of Products under
  Development for Vasculitis - Comparative
  Analysis, H2 2014 10Number of Products under
  Development by Companies, H2 2014 11Comparative
  Analysis by Late Stage Development, H2 2014
  13Comparative Analysis by Clinical Stage
  Development, H2 2014 14Comparative Analysis by
  Early Stage Development, H2 2014 15Products
  under Development by Companies, H2 2014
  16Vasculitis - Pipeline by AnGes MG, Inc., H2
  2014 17Vasculitis - Pipeline by Anthera
  Pharmaceuticals Inc., H2 2014 18Vasculitis -
  Pipeline by Aprogen, Inc., H2 2014 19Vasculitis
  - Pipeline by ChemoCentryx, Inc., H2 2014
  20Vasculitis - Pipeline by Clearside BioMedical,
  Inc., H2 2014 21Vasculitis - Pipeline by Epirus
  Biopharmaceuticals, Inc., H2 2014 22Vasculitis -
  Pipeline by F. Hoffmann-La Roche Ltd., H2 2014
  23Vasculitis - Pipeline by GlaxoSmithKline plc,
  H2 2014 24Vasculitis - Pipeline by Hemostemix
  Ltd, H2 2014 25

7
List of Figures

• Number of Products under Development for
  Vasculitis, H2 2014 9Number of Products under
  Development for Vasculitis - Comparative
  Analysis, H2 2014 10Number of Products under
  Development by Companies, H2 2014 11Comparative
  Analysis by Clinical Stage Development, H2 2014
  14Comparative Analysis by Early Stage Products,
  H2 2014 15Assessment by Monotherapy Products, H2
  2014 32Number of Products by Top 10 Targets, H2
  2014 33Number of Products by Stage and Top 10
  Targets, H2 2014 33Number of Products by Top 10
  Mechanism of Actions, H2 2014 35Number of
  Products by Stage and Top 10 Mechanism of
  Actions, H2 2014 35Number of Products by Top 10
  Routes of Administration, H2 2014 37Number of
  Products by Stage and Top 10 Routes of
  Administration, H2 2014 37Number of Products by
  Top 10 Molecule Types, H2 2014 39Number of
  Products by Stage and Top 10 Molecule Types, H2
  2014 39

8
Related Reports

• United States OffLabel Drugs Market Forecast
• Canada Pediatric Vaccines Market, Doses,
  Immunization (Vaccinated), Cases Forecast
• Intrauterine Contraceptive Devices Market
  (IUD/IUCD),by Type Hormonal IUCD, Copper IUCD
  Global Forecast to 2019
• Asian Healthcare Workflow Systems Market by Type
  (Fraud Detection, Pharmacy Audit Analysis,
  Claim Management System, Customer Relationship
  Management), by End-User - Forecast to 2019
• Healthcare IT (HIT) Market in the APAC Region
  2015-2019
• Complete 2015-16 Induced Pluripotent Stem Cell
  (iPSC) Industry Report
• Global Healthcare BPO Market 2015-2019

9
Follow Us
https//www.facebook.com/aarkstoredotcom
https//twitter.com/aarkstore
https//plus.google.com/Aarkstoredotcom/posts
https//www.linkedin.com/company/aarkstore-enterpr
ise
10
Contact Us
Office Address Office No. - 809, 8th
Floor,B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Mail us at
contact_at_aarkstore.com 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953